Gavin Malenfant
Chief Operating Officer at PROMIS NEUROSCIENCES, INC.
Net worth: 5 187 $ as of 2024-04-29
Network origin in Gavin Malenfant first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
| Public Company | Pharmaceuticals: Major | 6 | |
| Public Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gavin Malenfant via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Toronto | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| PERCHERON THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Virtua LLC | Founder Founder | ||
| GERON CORPORATION | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| VERNALIS | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CASSAVA SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Alberta | College/University | Undergraduate Degree Corporate Officer/Principal | |
Akashi Therapeutics Inc
 Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
| CHEMOMAB THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
| Providence College | College/University | Undergraduate Degree | |
| Simmons University | College/University | Graduate Degree | |
| GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
| Clinical Regulatory Services LLC | Founder | ||
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Director/Board Member | |
| PEGASYSTEMS INC. | Information Technology Services | Director/Board Member | |
| AMERESCO, INC. | Engineering & Construction | Investor Relations Contact | |
| Massachusetts College of Pharmacy & Health Science | College/University | Director/Board Member | |
Taligent, Inc.
 Taligent, Inc. Information Technology ServicesTechnology Services Part of HP, Inc., Taligent, Inc. designs software operating systems. Taligent was acquired by HP, Inc. from Apple, Inc. on January 06, 1994 for $10 million. | Information Technology Services | Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California San Diego | College/University | Doctorate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Berlex Laboratories, Inc. | General Counsel | ||
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Packaged Software | General Counsel | |
| Université Libre de Bruxelles | College/University | Doctorate Degree | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Seattle University | College/University | Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| United States | 42 |
| Canada | 5 |
| Australia | 2 |
| United Kingdom | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Technology Services | 4 |
| Commercial Services | 3 |
| Industrial Services | 2 |
Operational
| Director/Board Member | 96 |
| Corporate Officer/Principal | 72 |
| Director of Finance/CFO | 45 |
| Independent Dir/Board Member | 39 |
| Chief Tech/Sci/R&D Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| William Wyman | 21 |
| Anupam Dalal | 18 |
| Claude Nicaise | 16 |
| Gail Farfel | 15 |
| Neil Warma | 15 |
| Rita Jain | 14 |
| Karen L. Tubridy | 13 |
| Ben Price | 13 |
| Eugene Williams | 13 |
| Richard Barry | 12 |
| Mark de Rosch | 12 |
| Larry Altstiel | 12 |
| John C. Hodgman | 11 |
| Jean-Paul Kress | 10 |
- Stock Market
- Insiders
- Gavin Malenfant
- Company connections
